Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium (Q40931408)
scientific article published on August 1999
Language:
Current Data About Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium
(P31) (Q13442814)
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

(P304) 2148-2156
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

(P407) (Q1860)

(P433) 8
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

(P478) 5
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

(P577) Sunday, August 1, 1999
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

(P1433) (Q332253)
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

(P1476) "Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium" (language: en)
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

(P2093) H Shinohara
(P1545) 1
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

J J Killion
(P1545) 2
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

C D Bucana
(P1545) 3
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

S Yano
(P1545) 4
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

I J Fidler
(P1545) 5
(P248)
(P698) 10473099
(P813) Monday, September 25, 2017

other details
description scientific article published on August 1999

External Links
(P698) 10473099